Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor Treatment
Clinical trial NCT00234637 · COMPLETED
Trial details
- NCT number
- NCT00234637
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2003-11-01
- Primary completion
- 2005-06-01
- Enrollment
- 204
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.